-transparent.png){kind=logo}
Synovial fluid (SF) polymorphonuclear leucocytes (PMN) from patients with rheumatoid arthritis (RA) were compared to RA and normal circulating blood PMN. RA SF PMN were as viable as blood PMN and remained viable for up to 24 h in culture. Measurement of myeloperoxidase indicated that RA SF PMN had degranulated and secreted their myeloperoxidase prior to isolation, 26.5 +/- 11.7% being found extracellularly compared to less than 2.9% in RA and normal blood PMN. RA SF PMN alone showed a decrease in basal NADPH-oxidase activity as well as an increase in responsiveness to stimulation by chemotactic peptide during culture. Stimulation of PMN with phorbol-12-myrisitate-13-acetate evoked equivalent responses in each population before and after culture. These results demonstrate a major difference in resting and receptor-mediated activation of superoxide release by RA SF PMN. Together, these results have important implications in identifying the role of the activated PMN in RA.
E V Davies, and
B D Williams, and
A K Campbell
February 1990,
Clinical and experimental immunology,
E V Davies, and
B D Williams, and
A K Campbell
September 1990,
Annals of the rheumatic diseases,
E V Davies, and
B D Williams, and
A K Campbell
June 1990,
Clinical and experimental immunology,
E V Davies, and
B D Williams, and
A K Campbell
December 2002,
Inflammation,
E V Davies, and
B D Williams, and
A K Campbell
November 1974,
Clinical science and molecular medicine,
E V Davies, and
B D Williams, and
A K Campbell
January 1978,
Rheumatology and rehabilitation,
E V Davies, and
B D Williams, and
A K Campbell
January 1990,
Clinical and experimental rheumatology,
E V Davies, and
B D Williams, and
A K Campbell
January 1968,
Acta medica Polona,
E V Davies, and
B D Williams, and
A K Campbell
August 1991,
Matrix (Stuttgart, Germany),
E V Davies, and
B D Williams, and
A K Campbell
August 1990,
Annals of the rheumatic diseases,
